Search

Your search keyword '"Brain Chemistry drug effects"' showing total 656 results

Search Constraints

Start Over You searched for: Descriptor "Brain Chemistry drug effects" Remove constraint Descriptor: "Brain Chemistry drug effects" Journal european journal of pharmacology Remove constraint Journal: european journal of pharmacology
656 results on '"Brain Chemistry drug effects"'

Search Results

1. Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms.

2. Epigenetic upregulation of PSD-95 contributes to the rewarding behavior by morphine conditioning.

3. Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia.

4. The volatile anesthetic isoflurane differentially suppresses the induction of erythropoietin synthesis elicited by acute anemia and systemic hypoxemia in mice in an hypoxia-inducible factor-2-dependent manner.

5. 1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: Neurochemical correlates.

6. Modes of direct modulation by taurine of the glutamate NMDA receptor in rat cortex.

7. Anti-oxidative, anti-glycative and anti-apoptotic effects of oleanolic acid in brain of mice treated by D-galactose.

8. Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.

9. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.

10. Forced swimming and imipramine modify plasma and brain amino acid concentrations in mice.

11. Neuroadaptive changes in the rat brain GABA(B) receptors after withdrawal from cocaine self-administration.

12. SONU20176289, a compound combining partial dopamine D(2) receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression.

13. Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin.

14. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice.

15. Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats.

16. Centrally administered neuromedin U elevates plasma adrenaline by brain prostanoid TP receptor-mediated mechanisms in rats.

17. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor.

18. Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity.

19. Neuroprotective effects of emodin-8-O-beta-D-glucoside in vivo and in vitro.

20. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.

21. The anxiolytic effect of cinnabar involves changes of serotonin levels.

22. Persistence of tolerance to methamphetamine-induced monoamine deficits.

23. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.

24. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.

25. GABA(A) receptor changes in acute allopregnanolone tolerance.

26. Sensitization to morphine withdrawal in guinea-pigs.

27. Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes.

28. General anesthetics inhibit the nitrous-oxide-induced activation of corticotropin releasing factor containing neurons in rats.

29. Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats.

30. Involvement of the pineal gland in diurnal cocaine reward in mice.

31. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.

32. 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.

33. The mouse brain adenosine A1 receptor: functional expression and pharmacology.

34. L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice.

35. The anesthetics propofol and ketamine inhibit cocaine-induced egr-1 gene expression in rat forebrain.

36. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy.

37. Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain.

38. [(3)H]ZM241385--an antagonist radioligand for adenosine A(2A) receptors in rat brain.

39. Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells.

40. Increased plasma corticosterone, aggressiveness and brain monoamine changes induced by central injection of pertussis toxin.

41. 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation.

42. Comparative effects of dopamine D(1) and D(2) receptor antagonists on nerve growth factor protein induction.

43. 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice.

44. In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D(2) receptor agonists.

45. Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone.

46. Cocaine up-regulates norepinephrine transporter binding in the rat placenta.

47. Neuroadaptational changes in DNA binding of stimulatory protein-1 and nuclear factor-kB gene transcription factors during ethanol dependence.

48. Pharmacological re-evaluation of a GABA(B) receptor antagonist CGP 47332A in rat brain.

49. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.

50. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

Catalog

Books, media, physical & digital resources